About Aliri
Aliri is a Healthcare company based in Colorado Springs (United States) founded in 2009. CRO focused on drugs discovery, method development, and validation services. Aliri has raised $1.25 million across 2 funding rounds from investors including Siparex, European Union and Finovam Gestion. The company has 22 employees. Aliri has completed 1 acquisition, including Pyxant. Aliri offers products and services including Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its competitors include Pfizer, LabConnect and Ainos; 2 of its 3 listed competitors have raised funding.
Company details
Aliri was founded in 2009 and is based in Colorado Springs, United States. Operations are centered on contract research organization services within the pharmaceutical sector. Drug discovery processes are supported, alongside method development and validation for analytical and bioanalytical needs. Expertise is applied to assist clients in advancing therapeutic candidates through preclinical stages, with a focus on regulatory compliance and quality standards.
- Headquarters Colorado Springs, United States
- Employees 22
- SectorsHealthcare
- Website aliribio.com
- Social LinkedIn X
- Legal Name Aliri
Products & Services of Aliri
Aliri offers a comprehensive portfolio of products and services, including Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis.
Offers testing and method development for drug discovery programs.
Provides imaging and analysis for drug exposure and efficacy studies.
Develops and validates methods for sample analysis in pharmaceuticals.
Conducts assays and analysis for toxicity and pharmacokinetic studies.
Funding Insights of Aliri
Aliri has successfully raised a total of $1.25M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $337.01 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.25M
- Total Rounds 2
- Last Round Grant — $337,010
- First Round $1.25M
(Jun 2014)
- Investors Count 3
All 2 funding rounds of Aliri with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $337,010 | Grant | – | – | |
| Jun 2014 | $1.25M | Series A | – | Finovam Gestion, Siparex | – |
3 investors in total: 3 institutional.
Investors in Aliri
Aliri has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Siparex, European Union and Finovam Gestion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finovam Gestion is engaged in investing in future technological leaders. | finovamgestion.fr | Villeneuve d’Ascq, France | ||
Private equity investments are focused on growth stage companies. | 1977 | siparex.com | Paris, France | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Aliri
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aliri
18 people are tracked at Aliri (5 in leadership, 13 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
David Good | Senior Director Of Business Development | Leadership |
Alexandra Martin | Sr. Director, Business Development | Leadership |
Camille Latapy | Senior Director Of Business Development | Leadership |
Christian D. | Vice President Of Business Development | Leadership |
Mykhailo Tolkachov | Director Of Business Development | Leadership |
Michelle Hagfeldt | Lead Laboratory Accessioner | Team |
Chris Hardcastle | Research Associate II | Team |
Diane Pollock | Manager, Sample Management And Archives | Team |
Sola Karnik | Commercial Media Intern & Laboratory Support Staff | Team |
Pavithra Kuppusamy | Global Inside Sales Manager | Team |
Suzanne Newman | Paid Intern | Team |
Nick Brenchley | Archive Coordinator III | Team |
Qian Guo | Senior Associate Scientist | Team |
Olivia Franks | Client Manager | Team |
Sandra Delebecq | Assistante Ingénieure | Team |
Ghazanfar Ali | Principal Analytical Investigator Bioa | Team |
Cathleen Stewart | Laboratory Technician III | Team |
Shawn Burton | Principal Analytical Investigator II | Team |
Complete people profiles for Aliri
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aliri
Aliri has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pyxant.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
GLP bioanalytical services for drug development are provided by Pyxant. | pyxant.com | Colorado Springs, United States | 1984 | Jun 2021 | •••• |
Complete acquisition details for Aliri
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aliri
4 dated milestones of Aliri across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Aliri is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Grant, of $337K.
- Acquisition Acquires Pyxant.
Competitors of Aliri
Aliri has 3 listed competitors in our database, 2 of them funded. They include Pfizer, LabConnect and Ainos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| ainos.com | 1986 | San Diego, United States | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. |
Detailed competitors of Aliri
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aliri
The website of Aliri (aliribio.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 55.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aliri (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aliri
Complete news archive for Aliri
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aliri
Aliri was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Aliri is headquartered in Colorado Springs, United States. It is registered at Colorado Springs, Colorado, United States.
Aliri is a funded company, having raised a total of $1.25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $1.25M, raised on Jun 2014.
Aliri has 22 employees.
Aliri was founded in 2009 and is based in Colorado Springs, United States. Operations are centered on contract research organization services within the pharmaceutical sector. Drug discovery processes are supported, alongside method development and validation for analytical and bioanalytical needs. Expertise is applied to assist clients in advancing therapeutic candidates through preclinical stages, with a focus on regulatory compliance and quality standards.
Aliri's top competitors include Pfizer, LabConnect and Ainos.
Aliri offers Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis.
Aliri has made 1 acquisition, including Pyxant.
Aliri has 3 investors. Key investors include Siparex, European Union, and Finovam Gestion.
Aliri operates through Aliri.